Merck & Co., Inc. (MRK): Checking the Operational Data

Merck & Co., Inc. (NYSE:MRK) is an interesting stock at present. Now trading with a market value of 171.89B, the company has a mix of catalysts and obstacles that spring from the nature of its operations. As the day-to-day narrative ebbs and flows for this company, it is more important than ever to step back and get a bird’s eye view of the fundamental reality under the surface of this story.

Merck & Co., Inc. (NYSE:MRK) Fundamentals That Matter

It’s generally a good idea to start with the most fundamental piece of the picture: the balance sheet. The balance sheet health of any company plays a key role in its ability to meet its obligations and maintain the faith of its investment base. For MRK, the company currently has 11.71 billion of cash on the books, which is offset by 5.04 billion in current liabilities. The trend over time is important to note. In this case, the company’s debt has been falling. The company also has 96.56 billion in total assets, balanced by 56.47 billion in total liabilities, which should give you a sense of the viability of the company under any number of imagined business contexts.

Merck & Co., Inc. (MRK) saw -53 million in free cash flow last quarter, representing a quarterly net change in cash of 5.19 billion. Perhaps most importantly where cash movements are concerned, the company saw about 286 million in net operating cash flow.

Merck & Co., Inc. (NYSE:MRK) Revenue Growth Potential

As far as key trends that demonstrate something of the future investment potential of this stock, we need to take a closer look at the top line, first and foremost. Last quarter, the company saw 9.34 billion in total revenues. That represents a quarterly year/year change in revenues of 0.02 in sequential terms, the MRK saw sales decline by -0.08.

But what about the bottom line? After all, that’s what really matters in the end. Merck & Co., Inc. (MRK) is intriguing when broken down to its core data. The cost of selling goods last quarter was 2.88 billion, yielding a gross basic income of 6.46 billion. For shareholders, given the total diluted outstanding shares of 2.77 billion, this means overall earnings per share of 0.56. Note, this compares with a consensus analyst forecast of 0.87 in earnings per share for its next fiscal quarterly report.

Is Merck & Co., Inc. (NYSE:MRK) Valuation Attractive

Looking ahead at valuations, according to the consensus, the next fiscal year is forecast to bring about 4.19 in total earnings per share. If we consider a median price to earnings ratio on the stock, that corresponds with a stock price of 14.77. However, one should always remember: the trends are more important than the forecasts. This continues to be an interesting story, and we look forward to updating it again soon on Merck & Co., Inc..

Previous ArticleNext Article

Related Post

Coach, Inc. (COH) Sends Noticeable Signals on Tech... Coach, Inc. (NYSE:COH) gained 2.23% in Friday’s session, going up from its prior closing price of $39.47 to $40.35 The stock price went upward in 5 of...
Pacific Ethanol, Inc. (PEIX): Watch Out For Techni... Pacific Ethanol, Inc. (NASDAQ:PEIX) gained 9.20% in yesterday’s session, going up from its prior closing price of $4.35 to $4.75, and has now recorded...
Comparing Top Moving Stocks Parker Drilling Compan... The shares of Parker Drilling Company have decreased by more than -4.69% this year alone. The shares recently went up by 5.06% or $0.04 and now trades...
Choosing Between Calpine Corporation (CPN) and The... Calpine Corporation (NYSE:CPN) and The AES Corporation (NYSE:AES) are the two most active stocks in the Electric Utilities industry based on today’s t...
Which of 2 stocks would appeal to long-term invest... The shares of Teva Pharmaceutical Industries Limited have increased by more than 10.03% this year alone. The shares recently went up by 2.21% or $0.45...